Swiss Insurance Stock News

Implenia (SWX:IMPN) is back in focus after confirming its full year 2026 earnings guidance, targeting EBIT of around CHF 150 million before CHF 10 million to CHF 20 million of growth investments. The guidance confirmation comes after Implenia reported half year 2026 earnings on 18 August. The stock has responded with a 16.45% 90 day share price return and a 9.70% 30 day move, even though the year to date share price return is still down 11.27%, while the 5 year total shareholder return is...

TX Group stock has quietly climbed in recent weeks, yet today’s H1 earnings dropped a harsher reality check on profitability. The share price comes into this release riding solid short term gains, while the latest half shows a net loss of CHF 25.4 million and basic earnings per share of CHF 2.49 in the red. For a media group that lives and dies on cash generation, that margin and profit squeeze is the real story. The market now has to decide if recent optimism has run ahead of what the income...

Banque Cantonale de Genève stock has drifted over the past three months, with the share price down about 6%, yet H1 2026 earnings tell a firmer story. The market is wrestling with a bank that trades on a modest P/E of 9.1x while posting a trailing net profit margin of 43.4% and CHF 245.5m in net income over the last twelve months. The real headline today is profit quality. BCGE is pairing recent earnings with a balance of growth and capital discipline that investors will want to examine in...

EPIC Suisse entered this earnings season with a flat share price over the past month and a modest gain over three months, hardly the profile of a stock investors rush to reprice overnight. Yet behind the calm chart sits a headline result that matters. Reported net profit margins on a trailing basis are very high at 79.5%, and that figure is flattered by a sizeable CHF42.4m one off gain. The key question now is how much of EPIC Suisse’s recent earnings strength is repeatable once that boost is...

Luzerner Kantonalbank stock came into today with a quiet grind higher over the past quarter, then met an earnings release that puts sentiment under the microscope. Revenue for Q2 2026 reached CHF178.5m and net income came in at CHF81.4m, which keeps the profit engine running steadily. The real story sits in the margin picture. Net profit margin over the last year is reported at 45%, up from 43.2% a year earlier. For a regional Swiss bank this level of profitability can support a premium P/E,...

ORIOR walked into this earnings season wearing a value badge, trading on a P/E of 7.3x with the stock down over the past week and month, yet slightly higher over three months. The headline from H1 2026 is profit pressure. Net income from continuing operations over the last twelve months sat at CHF 12.7m on revenue of CHF 601.3m, which keeps the group in the black but under scrutiny for efficiency. For a food producer that lives and dies on margins and cash generation, the real story now is...

VP Bank shares closed at CHF94.20 on Wednesday, leaving the stock only modestly changed over the past month while the new earnings numbers raised sharper questions about earnings power. The key issue is margin. Over the last twelve months net profit margin reached 15.2%, compared with 10.4% a year earlier, and earnings increased 41.7% even though revenue growth stayed closer to 2.5%. The market is treating that combination with caution. Investors now have to consider whether this margin...

SoftwareOne Holding AG has reported past half-year 2026 results showing sales of CHF 818.3 million and net income of CHF 54.1 million, with basic earnings per share from continuing operations of CHF 0.25. The sharp rise in both revenue and profitability versus the prior-year period highlights a period of improved operating efficiency and earnings power for the business. Next, we will examine how this strong uplift in first-half 2026 sales and earnings reshapes SoftwareOne’s existing...

The European market has recently experienced a slight downturn, with the pan-European STOXX Europe 600 Index ending the week down amid global bond sell-offs and inflation concerns. Despite this cautious atmosphere, dividend stocks remain an attractive option for investors seeking steady income in uncertain times. In such a climate, selecting dividend stocks that offer robust yields and stable financials can be crucial for maintaining a balanced portfolio.

Shelly Group SE has entered a pan European partnership with ALSO Holding (SWX:ALSN), adding Shelly’s smart home and smart building portfolio to ALSO’s IoT focused distribution network across Europe. For investors watching ALSO Holding, the Shelly partnership comes after a mixed run in the stock. The share price is at CHF186.2, with a 90-day share price return of 5.68%, but a year-to-date share price return that has declined 13.6%. The 1-year total shareholder return is down 22.53%, which...

Last week, you might have seen that Siegfried Holding AG ( VTX:SFZN ) released its half-yearly result to the market...

Allreal Holding shares closed at CHF198.80 on 25 August, with the stock drifting lower over the past week and month. Yet today’s half year numbers tell a more nuanced story. Basic earnings per share of CHF6.39 and net income of CHF105.6m arrive against a backdrop of shrinking margins over the last twelve months and a large one off gain still sitting in the rear view mirror. The real fault line is not the headline profit; it is the pressure on profitability and the strain on cash flow backing...

Julius Bär Gruppe (SWX:BAER) is back in focus after research with EY on India’s family offices and the appointment of Nira Tanoko as South East Asia market head, both pointing investors toward its Asian wealth ambitions. See our latest analysis for Julius Bär Gruppe. Recent news on India’s family office growth and new leadership in South East Asia comes as Julius Bär Gruppe trades at CHF75.64, with a 30-day share price return of 7.2% and a 1-year total shareholder return of 32.1%. This...

Siegfried Holding stock went into this earnings print with a solid recent run, up about 13.5% over the past month and trading at CHF80.25, well above a discounted cash flow estimate of CHF59.01. The headline today is not a surprise beat or miss. It is a margin story. The company delivered a core EBITDA margin of 22.4% in the first half with management talking up further improvement above 23% for the full year. That mix of strong recent share gains, a richer price tag and quietly firming...

Why the 2026 ESC Congress Matters for Novartis Stock Novartis (SWX:NOVN) is back in focus after confirming plans to present data from 10 cardiovascular studies at the 2026 European Society of Cardiology Congress, including late breaking Leqvio and abelacimab results. See our latest analysis for Novartis. At a share price of CHF127.42, Novartis has shown firm momentum, with a 7 day share price return of 4.07%, a year to date share price return of 17.44%, and a 5 year total shareholder return...

With investors questioning the reliability of US Treasuries and the dollar at the same time, attention is drifting toward markets that feel calmer and more predictable. That shift can create openings and risks in stocks linked to Swiss and other safe haven currencies, as clients reconsider where they hold their cash and portfolios. This article walks through three stocks exposed to that story and explains how the current backdrop could matter for each one. The sample of stocks covered below...

VZ Holding (SWX:VZN) is back in focus after reporting half year 2026 earnings on 14 August. Net income reached CHF 131.69 million, with basic earnings per share from continuing operations at CHF 3.34. See our latest analysis for VZ Holding. The earnings release appears to have supported momentum in VZ Holding’s share price, with a 30 day share price return of 8.68% and a 90 day share price return of 18.54%. Over a longer period, the 5 year total shareholder return of 120.71% contrasts with a...

It's been a good week for Geberit AG ( VTX:GEBN ) shareholders, because the company has just released its latest...

Shareholders might have noticed that Straumann Holding AG ( VTX:STMN ) filed its interim result this time last week...

Emmi AG ( VTX:EMMN ) shareholders are probably feeling a little disappointed, since its shares fell 5.0% to CHF825 in...

Temenos (SWX:TEMN) has announced a share repurchase program of up to CHF 100 million, authorized by its Board on 12 August 2026 and running until late February 2027, primarily for general corporate uses. See our latest analysis for Temenos. At a latest share price of CHF 74.40, Temenos has seen a 30 day share price return of 11.54% and a 1 year total shareholder return of 5.84%, while the 5 year total shareholder return remains down 43.41%. This suggests that recent momentum has improved from...

Sandoz Group (SWX:SDZ) is back in focus after the company agreed a collaboration with Shanghai Henlius Biotech to develop, manufacture and commercialise up to 10 biosimilars, with milestone payments up to US$322 million. See our latest analysis for Sandoz Group. The collaboration news arrives as Sandoz Group trades at CHF73.84, with a 30 day share price return of 15.45% and a year to date share price return of 29.05%. Over the past year, total shareholder return of 48.82% indicates that...

Sensirion Holding shares closed at CHF78.90 on Friday after a choppy week that left the stock slightly lower over seven days but modestly higher over the past month. The market reaction feels cautious. The headline from these H1 numbers is clear. Profitability in the sensor business is tightening under the microscope. Revenue for the first half came in at CHF179.0m while basic earnings per share reached CHF1.21. The key development is in the trailing picture. Net profit margin on the last...

Roche Holding stock has delivered a 60.7% return over the past three years, and the recent run raises the question of whether the current price still lines up with what the valuation checks suggest. Over the past 3 years, Roche Holding has returned 60.7%, which puts recent gains front and centre in any assessment of what investors are now paying for the stock. Large ongoing investments in U.S. manufacturing capacity and diagnostics partnerships can support future cash generation. However,...